| Literature DB >> 29941651 |
Alessandra Piccirilli1, Mariagrazia Perilli1, Gianfranco Amicosante1, Viola Conte2, Carlo Tascini3, Gian Maria Rossolini4,5, Tommaso Giani6.
Abstract
TEM-184, a novel TEM-derived extended-spectrum β-lactamase (ESBL), was isolated from an Escherichia coli ST354 clinical strain. Compared to TEM-1, TEM-184 contains the mutations Q6K, E104K, I127V, R164S, and M182T. Kinetic analysis of this enzyme revealed extended-spectrum activity against aztreonam in particular. TEM-184 was also susceptible to inhibitors, including clavulanic acid, tazobactam, and avibactam.Entities:
Keywords: ESBL; avibactam; inhibitors
Mesh:
Substances:
Year: 2018 PMID: 29941651 PMCID: PMC6125571 DOI: 10.1128/AAC.00688-18
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191